Literature DB >> 21363906

Bipolar medication use and adherence to antiretroviral therapy among patients with HIV-AIDS and bipolar disorder.

James T Walkup1, Ayse Akincigil, Sujoy Chakravarty, Mark Olfson, Scott Bilder, Shahla Amin, Michele J Siegel, Stephen Crystal.   

Abstract

OBJECTIVE: The study examined relationships between adherence to bipolar medication and to antiretroviral therapy, measured by medication fills, among patients with diagnoses of bipolar disorder and HIV infection.
METHODS: A retrospective study was conducted of Medicaid claims data (2001-2004) from eight states, focusing on antiretroviral adherence. The unit of analysis was person-month (N=53,971). The average observation period for the 1,687 patients was 32 months. Analyses controlled for several patient characteristics.
RESULTS: Patients possessed antiretroviral drugs in 72% of the person-months. When a bipolar medication prescription was filled in the prior month, the rate of antiretroviral possession in the subsequent month was 78%, compared with 65% when bipolar medication was not filled in the prior month (p<.001). Odds of antiretroviral possession were 66% higher in months when patients had a prior-month supply of bipolar medication.
CONCLUSIONS: Bipolar medication adherence may improve antiretroviral adherence among patients with bipolar disorder and HIV infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21363906     DOI: 10.1176/ps.62.3.pss6203_0313

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  2 in total

1.  Does Diagnosis Make a Difference? Estimating the Impact of an HIV Medication Adherence Intervention for Persons with Serious Mental Illness.

Authors:  Natasha Dalseth; Regina Szucs Reed; Michael Hennessy; Marlene M Eisenberg; Michael B Blank
Journal:  AIDS Behav       Date:  2018-01

2.  Bipolar disorder is associated with HIV transmission risk behavior among patients in treatment for HIV.

Authors:  Christina S Meade; Lisa A Bevilacqua; Mary D Key
Journal:  AIDS Behav       Date:  2012-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.